FIELD: medicine, pharmaceutical technology, pharmacy. SUBSTANCE: invention relates to solid medicinal form preparing by extrusion and the following shaping solvent-free melt that comprise both one or and some active substances: A) from 2 to 90 wt.-% of thermoplastic water-soluble polymer; B) from 5 to 89.9 wt.-% of isomalt, and C) from 0 to 5 wt.-% of lecithin. Prepared forms show high rate of release of drug and good stability. EFFECT: improved quality and properties of forms. 7 cl, 13 ex
| Title | Year | Author | Number |
|---|---|---|---|
| SOLID, PARTIALLY OR FULLY FROTHED PREPARATIONS OF ACTIVE COMPONENT | 1997 |
|
RU2200004C2 |
| METHOD OF PRODUCING COATED TABLETS | 1995 |
|
RU2177310C2 |
| PROLONGED-EFFECT MATRIX GRANULES | 1995 |
|
RU2155031C2 |
| HEPARIN-BASE FORMULATION | 2001 |
|
RU2278658C2 |
| OBTAINING SOLID MEASURED FORMS USING CROSS-LINKED NON-THERMOPLASTIC CARRIER | 2003 |
|
RU2344809C2 |
| COMPOSITION AND DOSAGE FORM CONTAINING SOLID OR SEMISOLID MATRIX | 2006 |
|
RU2423997C9 |
| PHARMACEUTICALLY ACCEPTABLE SOLUBILISING COMPOSITION AND PHARMACEUTICAL DOSAGE FORM CONTAINING IT | 2007 |
|
RU2469708C2 |
| METHOD AND DEVICE FOR MANUFACTURING DIVISIBLE TABLETS | 1995 |
|
RU2181582C2 |
| PHARMACEUTICAL DOSED FORM, CONTAINING POLYMER CARRIER COMPOSITION | 2009 |
|
RU2519679C9 |
| COMPOSITION CONTAINING PHENOFIBRIN ACID, ITS PHYSIOLOGICALLY ACCEPTABLE SALT OR DERIVATIVE | 2003 |
|
RU2356549C2 |
